FOXM1 in cancer: Interactions and vulnerabilities

Cancer Research

Volumn 77, Issue 12, 2017, Pages 3135-3139

  Gartel, Andrei L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CENTROMERE PROTEIN F; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; FORKHEAD BOX PROTEIN M1; HEAT SHOCK PROTEIN 70; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA PVT1; MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; MICRORNA; MICRORNA 101; MICRORNA 27A; NUCLEOPHOSMIN; PEPTIDYL PROLYL CIS TRANS ISOMERASE NIMA INTERACTING 1; PROTEIN SERINE THREONINE KINASE; SMAD3 PROTEIN; SMAD4 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ACUTE MYELOID LEUKEMIA; CANCER PROGNOSIS; CARCINOGENESIS; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA CELL LINE; CYTOPLASM; DOWN REGULATION; ENZYME ACTIVITY; GENE MUTATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; METASTATIC MELANOMA; NONHUMAN; NPM1 GENE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PHYSIOLOGY;

ANIMALS; FORKHEAD BOX PROTEIN M1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 85021049318     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-16-3566     Document Type: Review

References (30)

1. Laoukili J, Stahl M, Medema RH. FoxM1: At the crossroads of ageing and cancer. Biochim Biophys Acta 2007;1775:92-102.
2. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grutzmann R. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia 2004;6:744-50.
3. Halasi M, Gartel AL. FOX(M1) News - It Is Cancer. Mol Cancer Ther 2013;12:245-54.
4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
5. Bhat UG, Jagadeeswaran R, Halasi M, Gartel AL. Nucleophosmin interacts withFOXM1and modulates the level and localization ofFOXM1in human cancer cells. J Biol Chem 2011;286:41425-33.
6. Pandit B, Halasi M, Gartel AL. p53 negatively regulates expression of FoxM1. Cell Cycle 2009;8:3425-7.
7. Barsotti AM, Prives C. Pro-proliferative FoxM1 is a target of p53-mediated repression. Oncogene 2009;28:4295-305.
8. Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med 2015;21:938-45.
9. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005;352:254-66.
10. Quentmeier H, Martelli MP, Dirks WG, Bolli N, Liso A, Macleod RA, et al. Cell line OCI/AML3 bears exon-12NPM gene mutation-A and cytoplasmic expression of nucleophosmin. Leukemia 2005;19:1760-7.
11. Khan I, Halasi M, Zia MF, Gann P, Gaitonde S, Mahmud N, Gartel AL. Nuclear FOXM1drives chemoresistance inAML. Leukemia 2017;31, 251-5.
12. Ganguly R, Hong CS, Smith LG, Kornblum HI, Nakano I. Maternal embryonic leucine zipper kinase: key kinase for stem cell phenotype in glioma and other cancers. Mol Cancer Ther 2014;13:1393-8.
13. Joshi K, Banasavadi-Siddegowda Y, Mo X, Kim SH, Mao P, Kig C, et al. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells. Stem Cells 2013;31:1051-63.
14. Radhakrishnan SK, Bhat UG, Hughes DE, Wang IC, Costa RH, Gartel AL. Identification of a Chemical Inhibitor of the Oncogenic Transcription Factor Forkhead Box M1. Cancer Res 2006;66:9731-35.
15. Bhat UG, Halasi M, Gartel AL. FoxM1 is a general target for proteasome inhibitors. PLoS One 2009;4:e6593.
16. Kruiswijk F, Hasenfuss SC, Sivapatham R, Baar MP, Putavet D, Naipal KA, et al. Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling. Oncogene 2016;35: 2166-77.
17. Maachani UB, Shankavaram U, Kramp T, Tofilon PJ, Camphausen K, Tandle AT. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells. Oncotarget 2016;7:77365-77.
18. Jin B, Wang C, Li J, Du X, Ding K, Pan J. Anthelmintic niclosamide disrupts the interplay of p65 and FOXM1/beta-catenin and eradicates leukemia stem cells in chronic myelogenous leukemia. Clin Cancer Res 2017;23:789-803.
19. Xu MD, Wang Y,WengWW,Wei P, Qi P, Zhang Q, et al. A positive feedback loop of lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and invasion. Clin Cancer Res 2017;23:2071-80.
20. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-80.
21. Ma S, Tang KH, Chan YP, Lee TK, Kwan PS, Castilho A, et al. miR-130b promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein. Cell Stem Cell 2010;7:694-707.
22. Zhang N, Wei P, Gong A, Chiu WT, Lee HT, Colman H. FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell 2011;20:427-42.
23. Xue J, Lin X, Chiu WT, Chen YH, Yu G, Liu M,et al. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-beta-dependent cancer metastasis. J Clin Invest 2014;124:564-79.
24. Sundqvist A, Ten Dijkevan Dam P. Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity. Breast Cancer Res 2012;14:204.
25. Pan Y, Li J, Zhang Y, Wang N, Liang H, Liu Y, et al. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression. Sci Rep 2016;6:25798.
26. Halasi M, Gartel AL. A novel mode of FoxM1 regulation: positive autoregulatory loop. Cell Cycle 2009;8:1966-7.
27. Halasi M, Varaljai R, Benevolenskaya E, Gartel AL. A novel function of molecular chaperone HSP70: suppression of oncogenic foxm1 after proteotoxic stress. J Biol Chem 2016;291:142-8.
28. Aytes A, Mitrofanova A, Lefebvre C, Alvarez MJ,Castillo-MartinM, Zheng T, et al. Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. Cancer Cell 2014;25:638-51.
29. Xu M, Qin J, Tsai SY, Tsai MJ. The role of the orphan nuclear receptor COUP-TFII in tumorigenesis. Acta Pharmacol Sin 2015;36: 32-6.
30. Lin SC, Kao CY, Lee HJ, Creighton CJ, Ittmann MM, Tsai SJ, et al. Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer. Nat Commun 2016;7: 11418.